Early research (Phase 1)Study completedNCT01682135What this trial is testingA Study in Participants With Advanced Solid TumorsWho this might be right forSolid Tumor Eli Lilly and Company 28
Testing effectiveness (Phase 2)Looking for participantsNCT04924075What this trial is testingBelzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)Who this might be right forPheochromocytoma/ParagangliomaPancreatic Neuroendocrine TumorVon Hippel-Lindau Disease+2 more Merck Sharp & Dohme LLC
Early research (Phase 1)Ended earlyNCT07159828What this trial is testingAssess AXN-2510 Treatment in Adult Patients With Advanced Solid TumorsWho this might be right forSolid Tumor, Adult Axion Bio, Inc 3
Early research (Phase 1)Study completedNCT01482377What this trial is testingRO5479599 Alone or in Combination With Cetuximab or Erlotinib in Participants With Metastatic and/or Locally Advanced Malignant Human Epidermal Growth Factor Receptor (HER3) Expressing Solid Tumors of Epithelial Cell OriginWho this might be right forNeoplasms Hoffmann-La Roche 145
Early research (Phase 1)Active Not RecruitingNCT03842228What this trial is testingTesting the Combination of the Anti-cancer Drugs Copanlisib, Olaparib, and MEDI4736 (Durvalumab) in Patients With Advanced Solid Tumors With Selected MutationsWho this might be right forAdvanced Malignant Solid NeoplasmMetastatic Malignant Solid NeoplasmUnresectable Malignant Solid Neoplasm National Cancer Institute (NCI) 39
Early research (Phase 1)Study completedNCT00502567What this trial is testingAssess Safety, Tolerability and PK of AZD2171 and Chemotherapy on Patients With Solid TumorsWho this might be right forAdvanced Solid Tumor AstraZeneca 104
Not applicableActive Not RecruitingNCT06432283What this trial is testingA Machine Learning-based Estimated Survival ModelWho this might be right forAdvanced Solid Tumor Zhao Siyao 1,000
Very early researchLooking for participantsNCT06346041What this trial is testingSafety and Efficacy of Intravenous IDOV-SAFETM in Patients With Advanced Solid TumorsWho this might be right forNeoplasms Cancer Institute and Hospital, Chinese Academy of Medical Sciences 19
Early research (Phase 1)Study completedNCT00415324What this trial is testingEribulin Mesylate and Cisplatin in Treating Patients With Advanced Solid TumorsWho this might be right forUnspecified Adult Solid Tumor, Protocol Specific National Cancer Institute (NCI) 36
Testing effectiveness (Phase 2)Study completedNCT00810394What this trial is testingSorafenib in Treating Patients With Advanced Malignant Solid TumorsWho this might be right forUnspecified Adult Solid Tumor, Protocol Specific University of California, Davis 50
Early research (Phase 1)WithdrawnNCT05472220What this trial is testingAlpelisib in Combination With Carboplatin in Patients With Solid Tumors and HPV-Positive Squamous Cell CarcinomaWho this might be right forSolid Tumors, AdultPIK3CA Mutation-Related TumorsPIK3CA Mutation+5 more Pamela Munster
Testing effectiveness (Phase 2)Study completedNCT02611024What this trial is testingPharmacokinetic Study of Lurbinectedin in Combination With Irinotecan in Patients With Selected Solid TumorsWho this might be right forAdvanced Solid TumorsGlioblastomaSoft Tissue Sarcoma (Excluding GIST)+9 more PharmaMar 316
Early research (Phase 1)Study completedNCT01128842What this trial is testingNeratinib (HKI-272) And Capecitabine In Japanese With Solid TumorWho this might be right forAdvanced Malignant Solid Tumors Puma Biotechnology, Inc. 7
Testing effectiveness (Phase 2)Study completedNCT05975073What this trial is testingAnvumetostat in Combination With IDE397 in Participants With Advanced Methylthioadenosine Phosphorylase (MTAP)-Null Solid TumorsWho this might be right forMTAP-null Non-Small-Cell Lung CancerMTAP-null Solid Tumors Amgen 53
Testing effectiveness (Phase 2)Active Not RecruitingNCT06939283What this trial is testingA Phase 1b/2 Multisite Dose-finding and Expansion Study of WTX-330 in Adult Patients With Selected Advanced or Metastatic Solid Tumors or LymphomaWho this might be right forAdvanced or Metastatic Solid TumorsNon-Hodgkin Lymphoma Werewolf Therapeutics, Inc. 100
Early research (Phase 1)Study completedNCT04097769What this trial is testingThe Safety, Tolerability, and Initial Efficacy of HX009 in Patients With Advanced MalignanciesWho this might be right forAdvanced Solid Tumor Waterstone Hanxbio Pty Ltd 21
Early research (Phase 1)Study completedNCT01762280What this trial is testingA Phase I Study of Famitinib Malate in Patients With Solid TumorWho this might be right forAdvanced Solid Tumor Jiangsu HengRui Medicine Co., Ltd. 55
Early research (Phase 1)Looking for participantsNCT07252479What this trial is testingEvaluation of RAS Inhibitor Treatment in Participants With Advanced or Metastatic Solid Tumors Harboring RAS MutationsWho this might be right forSolid Tumors (Phase 1)RAS Mutation Adlai Nortye Biopharma Co., Ltd. 118
Early research (Phase 1)UnknownNCT04758897What this trial is testingClinical Study of VG161 in Subjects With Advanced Malignant Solid TumorsWho this might be right forAdvanced Malignant Solid Tumor CNBG-Virogin Biotech (Shanghai) Ltd. 18
Early research (Phase 1)Ended earlyNCT06457997What this trial is testingPHN-010 in Patients With Advanced Solid TumorsWho this might be right forLung CancerColon CancerEndometrial Cancer+4 more Pheon Therapeutics 26